Trial intelligence / Profile preview

Preoperative-night dexmedetomidine to prevent postoperative delirium after hip-fracture surgery in elderly patients

ChiCTR2400087107Phase 4Recruiting

Sponsor
Shidong Hospital
Start
Jul 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in postoperative delirium (POD) comparing Dexmedetomidine infusion with Placebo (normal saline) infusion (2 arms). Primary endpoint: Incidence of postoperative delirium. Started Jul 2024; status: recruiting.

02

Drugs

dexmedetomidine
03

Conditions

postoperative delirium (POD)

Beyond the preview

Go deeper on ChiCTR2400087107.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400087107.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call